최근 5년(2006-2010)간 소아 혈액 종양 환자에서 발생한 균혈증의 원인균 및 임상 양상: 단일기관 연구
Etiological Agents in Bacteremia of Children with Hemato-oncologic Diseases (2006-2010): A Single Center Study
0
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
목 적 : 소아 종양 환자의 균혈증의 원인균과 위험 인자에 대한 지속적인 감시 및 조사를 통해 적절한 치료와 생존율 향상에 기여하고자, 2006년부터 2010년의 최근 5년간 서울대학교 어린이 병원 소아 종양 환자에게 발생했던 균혈증의 원인균 분포와 이들의 항생제 감수성을 분석하여 항생제 선택에 실제적인 도움을 얻고자 하였다. 방 법: 2006년 1월부터 2010년 12월까지 5년간 서울대학교 어린이병원에서 입원 치료를 받은 소아 종양환자들에게 발생한 균혈증에 대하여, 의무기록을 후향적으로 분석하였다. 의무기록 분석 시, 선행 질환 및 호중구 수치, 치료 경과 등을 조사하였고, 호중구 감소증, 중심 정맥관 등 균혈증의 예후 인자에 대한 분석을 함께 시행하였다. 결 과:총 176명의 소아 종양 환자에게 226례의 균혈증이 발생하였고, 246균주가 분리되었다. 이 중 그람 음성균, 그람 양성균, 진균이 각각 63.4%, 34.6%, 2.0%이었다. 그람 음성균 중에는 Klebsiella species, E. coli, 그람 양성균 중에는 coagulase-negative staphylococci, S. aureus 등이 높은 비율로 분리되었다. 그람 양성균의penicillin, oxacillin, vanconycmin 내성률은 각각 85.7%, 65.9%, 9.5%이었으며, 그람 음성균의 cefotaxime, piperacillin/tazobactam, imipenem, gentamicin, ami-kacin 내성률은 각각 37.2%, 17.1%, 6.2%, 32.2%, 13.7%이었다. 전체 환자에서 치사율은 12.7%였다. 그람음성균 균혈증의 쇼크 발생률이 그람 양성균 균혈증보다유의하게 높았고(48.4% vs. 11.9%, P <0.01), 치사율역시 그람 음성균이 더 높았다(12.1% vs. 3.0%, P =0.03). 쇼크 발생률은 호중구 감소증을 동반한 환자군에서 호중구 감소증을 동반하지 않은 환자군에서보다 유의하게 높았다(39.6% vs. 22.0%, P =0.04). 결 론 : 그람 음성균이 소아 종양 환자의 균혈증의 흔한 원인균이며, 불량한 예후와도 관련성이 높은 점들은기존 연구결과들과 일치하였다. 향후 원인 균주의 분포와 항생제 내성률의 변화에 대한 지속적인 모니터링이필요할 것으로 생각된다.
Abstract
Purpose : This study was performed to identify the etiologic agents and antimicrobial susceptibility patterns of organisms responsible for bloodstream infections in pediatric cancer patients for guidance in empiric antimicrobial therapy. Methods : A 5-year retrospective study of pediatric hemato-oncologic patients with bacteremia in Seoul National University Children's Hospital, from 2006 to 2010 was conducted. Results : A total of 246 pathogens were isolated, of which 63.4% (n=156) were gram-negative, bacteria 34.6% (n=85) were gram-positive bacteria, and 2.0% (n=5) were fungi. The most common pathogens were Klebsiella spp. (n=61, 24.8%) followed by Escherichia coli (n=31, 12.6%), coagulase-negative staphylococci (n=23, 9.3%), and Staphylococcus aureus (n=22, 8.9%). Resistance rates of gram-positive bacteria to penicillin, oxacillin, and vancomycin were 85.7%, 65.9%, and 9.5%, respectively. Resistance rates of gram-negative bacteria to cefotaxime, piperacillin/tazobactam, imipenem, gentamicin, and amikacin were 37.2%, 17.1%, 6.2%, 32.2%, and 13.7%, respectively. Overall fatality rate was 12.7%. Gram-negative bacteremia was more often associated with shock (48.4% vs. 11.9%, P <0.01) and had higher fatality rate than gram-positive bacteremia (12.1% vs. 3.0%, P =0.03). Neutropenic patients were more often associated with shock than non-neutropenic patients (39.6% vs. 22.0%, P =0.04). Conclusion : This study revealed that gram-negative bacteria were still dominant organisms of bloodstream infections in children with hemato-oncologic diseases, and patients with gram-negative bacteremia showed fatal course more frequently than those with gram-positive bacteremia.
참고문헌 (30)
- Nelson DS, "Spectrum and frequency of pediatric illness presenting to a general community hospital emergency department", Pediatrics, 90, pp.5~10 (1992)
- Baskin MN, "The prevalence of serious bacterial infections by age in febrile infants during the first 3 months of life", Pediatr Ann, 22, pp.462~466 (1993)
- DeAngelis C, "Iatrogenic risks and financial costs of hospitalizing febrile infants", Am J Dis Child, 137, pp.1146~1149 (1983)
- Dagan R, "Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis", J Pediatr, 107, pp.855~860 (1985)
- Dagan R, "Ambulatory care of febrile infants younger than 2 months of age classified as being at low risk for having serious bacterial infections", J Pediatr, 112, pp.355~360 (1988)
- Baker MD, "Outpatient management without antibiotics of fever in selected infants", N Eng J Med, 329, pp.1439~1441 (1993)
- 이준호, "Etiology of Invasive Bacterial Infections in Immunocompetent Children in Korea (1996-2005): A Retrospective Multicenter Study", Journal of Korean Medical Science, 26(2), pp.174~183 (2011), 대한의학회
- Levine DA, "Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections", Pediatrics, 113, pp.1728~1734 (2004)
- Gómez B, "Blood culture and bacteremia predictors in infants less than three months of age with fever without source", Pediatr Infect Dis J, 29, pp.43~47 (2010)
- Bressan S, "Predicting severe bacterial infections in well-appearing febrile neonates: laboratory markers accuracy and duration of fever", Pediatr Infect Dis J, 29, pp.227~232 (2010)
- The WHO Young Infants Study Group, "Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study", Pediatr Infect Dis J, 18, pp.17~22 (1999)
- Dagan R, "Epidemiology and laboratory diagnosis of infection with viral and bacterial pathogens in infants hospitalized for suspected sepsis", J Pediatr, 115, pp.351~356 (1989)
- 신승한, "Risk Factors for Serious Bacterial Infection in Febrile Young Infants in a Community Referral Hospital", Journal of Korean Medical Science, 24(5), pp.844~848 (2009), 대한의학회
- Nah SY, "Etiology and clinical features of acute viral lower respiratory tract infection in apparently healthy children", Korean J Pediatr, 39, pp.1690~1699 (1996)
- 권정현, "2002-2006년 서울지역 입원 환자에서의 급성 바이러스성하기도염의 역학조사", Allergy Asthma & Respiratory Diseases, 18(1), pp.26~36 (2008), 대한 소아알레르기 호흡기학회
- Byington CL, "Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections", Pediatrics, 113, pp.1662~1666 (2004)
- Titus MO, "Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection", Pediatrics, 112, pp.282~284 (2003)
- Yarden-Bilavsky H, "Month-by-month age analysis of the risk for serious bacterial infections in febrile infants with bronchiolitis", Clin Pediatr, 50, pp.1052~1056 (2011)
- Huppler AR, "Performance of low-risk criteria in the evaluation of young infants with fever: review of the literature", Pediatrics, 125, pp.228~233 (2010)
- Baskin MN, "Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone", J Pediatr, 120, pp.22~27 (1992)
- Baker MD, "The efficacy of routine outpatient management without antibiotics of fever in selected infants", Pediatrics, 103, pp.627~631 (1999)
- Bachur RG, "Predictive model for serious bacterial infections among infants younger than 3 months of age", Pediatrics, 108, pp.311~316 (2001)
- Kourtis A, "Practice guidelines for the management of febrile infants less than 90 days of age at the ambulatory network of a large pediatric health care system in the United States: summary of new evidence", Clin Pediatr, 43, pp.11~16 (2004)
- Baraff LJ, "Management of infants and young children with fever without source", Pediatr Ann, 37, pp.673~679 (2008)
- Putto A, "C reactive protein in the evaluation of febrile illness", Arch Dis Child, 61, pp.24~29 (1986)
- Pulliam PN, "C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection", Pediatrics, 108, pp.1275~1279 (2001)
- Baraff LJ, "Practice guideline for the manage ment of infants and children 0 to 36 months of age with fever without source", Ann Emerg Med, 22, pp.1198~1210 (1993)
- Baker MD, "Evaluation and management of infants with fever", Pediatr Clin North Am, 46, pp.1061~1072 (1999)
- Elder JS, "Urinary tract infections, In Nelson textbook of pediatrics. 19th ed", pp.1829~ (2011), Saunders Elsevier
- Libster R, "Breastfeeding prevents severe disease in full term female infants with acute respiratory infection", Pediatr Infect Dis J, 28, pp.131~134 (2009)